Long-term effects of coffee and caffeine intake on the risk of pre-diabetes and type 2 diabetes: Findings from a population with low coffee consumption

Nutr Metab Cardiovasc Dis. 2018 Dec;28(12):1261-1266. doi: 10.1016/j.numecd.2018.09.001. Epub 2018 Sep 12.

Abstract

Background and aim: Here, we examined the potential effect of coffee consumption and total caffeine intake on the occurrence of pre-diabetes and T2D, in a population with low coffee consumption.

Methods and results: Adults men and women, aged 20-70 years, were followed for a median of 5.8 y. Dietary intakes of coffee and caffeine were estimated using a 168-food items validate semi-quantitative food frequency questionnaire, at baseline. Cox proportional hazards regression models, adjusted for potential cofounders, were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between coffee and caffeine intakes and incidence of pre-diabetes and T2D. The total population was 1878 adults (844 men, 1034 women) and 2139 adults (971 men, 1168 women) for analysis of pre-diabetes and T2D, respectively. During the follow-up period the incidence of pre-diabetes and T2D was 30.8% and 6.6%, respectively. Forty-three percent of our subjects were no coffee drinker whereas 51.4% consumed 1 cup of coffee/week and 6.0% consumed more than 1 cup of coffee/week. A lower risk of pre-diabetes (HR = 0.73, 95% CI = 0.62-0.86) and T2D (HR = 0.66, 95% CI = 0.44-1.00) was observed in coffee drinkers compared to non-drinkers, in the fully adjusted models. Higher dietary intake of caffeine (≥152 vs. <65 mg/d) was accompanied with a borderline (P = 0.053) reduced risk of pre-diabetes (HR = 0.45, 95% CI = 0.19-1.00).

Conclusion: Our findings indicated that coffee drinking may have favorable effect in prevention of pre-diabetes and T2D.

Keywords: Caffeine; Coffee; Pre-diabetes; Type 2 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Caffeine / administration & dosage*
  • Central Nervous System Stimulants / administration & dosage*
  • Coffee*
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / epidemiology*
  • Diabetes Mellitus, Type 2 / prevention & control*
  • Female
  • Humans
  • Incidence
  • Iran / epidemiology
  • Male
  • Middle Aged
  • Prediabetic State / diagnosis
  • Prediabetic State / epidemiology*
  • Prediabetic State / prevention & control*
  • Prospective Studies
  • Protective Factors
  • Risk Factors
  • Risk Reduction Behavior
  • Time Factors
  • Young Adult

Substances

  • Central Nervous System Stimulants
  • Coffee
  • Caffeine